These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17961089)

  • 1. Electroporation-based DNA immunisation: translation to the clinic.
    Luxembourg A; Evans CF; Hannaman D
    Expert Opin Biol Ther; 2007 Nov; 7(11):1647-64. PubMed ID: 17961089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses.
    Wang Q; Jiang W; Chen Y; Liu P; Sheng C; Chen S; Zhang H; Pan C; Gao S; Huang W
    J Virol; 2014 Feb; 88(4):1924-34. PubMed ID: 24284319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2014; 10(10):3039-47. PubMed ID: 25483486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNA.
    Ohlschläger P; Spies E; Alvarez G; Quetting M; Groettrup M
    Int J Cancer; 2011 Jan; 128(2):473-81. PubMed ID: 20309939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant.
    Zhang L; Widera G; Rabussay D
    Bioelectrochemistry; 2004 Jun; 63(1-2):369-73. PubMed ID: 15110305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroporation for DNA immunization: clinical application.
    van Drunen Littel-van den Hurk S; Hannaman D
    Expert Rev Vaccines; 2010 May; 9(5):503-17. PubMed ID: 20450325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.
    Huang X; Zhu Q; Huang X; Yang L; Song Y; Zhu P; Zhou P
    Vaccine; 2017 Apr; 35(16):2042-2051. PubMed ID: 28318765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of electroporation in DNA vaccination protocols.
    Chiarella P; Fazio VM; Signori E
    Curr Gene Ther; 2010 Aug; 10(4):281-6. PubMed ID: 20504275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation.
    Dolter KE; Evans CF; Ellefsen B; Song J; Boente-Carrera M; Vittorino R; Rosenberg TJ; Hannaman D; Vasan S
    Vaccine; 2011 Jan; 29(4):795-803. PubMed ID: 21094270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer vaccination by electro-gene-transfer.
    Aurisicchio L; Mancini R; Ciliberto G
    Expert Rev Vaccines; 2013 Oct; 12(10):1127-37. PubMed ID: 24066796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?
    Frelin L; Brass A; Ahlén G; Brenndörfer ED; Chen M; Sällberg M
    Drug News Perspect; 2010 Dec; 23(10):647-53. PubMed ID: 21180650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation.
    Hannaman D; Dupuy LC; Ellefsen B; Schmaljohn CS
    Vaccine; 2016 Jun; 34(31):3607-12. PubMed ID: 27206386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers.
    Diehl MC; Lee JC; Daniels SE; Tebas P; Khan AS; Giffear M; Sardesai NY; Bagarazzi ML
    Hum Vaccin Immunother; 2013 Oct; 9(10):2246-52. PubMed ID: 24051434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccines, electroporation and their applications in cancer treatment.
    Lee SH; Danishmalik SN; Sin JI
    Hum Vaccin Immunother; 2015; 11(8):1889-900. PubMed ID: 25984993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep.
    Babiuk S; Tsang C; van Drunen Littel-van den Hurk S; Babiuk LA; Griebel PJ
    Bioelectrochemistry; 2007 May; 70(2):269-74. PubMed ID: 17118714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery systems for gene-based vaccines.
    Dubensky TW; Liu MA; Ulmer JB
    Mol Med; 2000 Sep; 6(9):723-32. PubMed ID: 11071268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroporation-enhanced delivery of nucleic acid vaccines.
    Broderick KE; Humeau LM
    Expert Rev Vaccines; 2015 Feb; 14(2):195-204. PubMed ID: 25487734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid DNA vaccination using skin electroporation promotes poly-functional CD4 T-cell responses.
    Bråve A; Nyström S; Roos AK; Applequist SE
    Immunol Cell Biol; 2011 Mar; 89(3):492-6. PubMed ID: 20838412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short noncoding DNA fragments improve the immune potency of electroporation-mediated HBV DNA vaccination.
    Peng J; Shi S; Yang Z; Ding Q; Hai W; Tang H; Yang Y; Bernstein JR; Peyda P; Xu Y
    Gene Ther; 2014 Jul; 21(7):703-8. PubMed ID: 24830435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A; Hannaman D; Nolan E; Ellefsen B; Nakamura G; Chau L; Tellez O; Little S; Bernard R
    Vaccine; 2008 Sep; 26(40):5216-22. PubMed ID: 18462850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.